CP-100356 hydrochloride

Modify Date: 2024-01-09 12:40:24

CP-100356 hydrochloride structure	Common Name	CP-100356 hydrochloride
	CAS Number	142715-48-8	Molecular Weight	597.10200
	Density	N/A	Boiling Point	N/A
	Molecular Formula	C₃₁H₃₇ClN₄O₆	Melting Point	N/A
	MSDS	USA	Flash Point	N/A

Use of CP-100356 hydrochloride

CP-100356 hydrochloride is an orally active dual MDR1 (P-gp)/BCRP inhibitor, with an IC50s of 0.5 and 1.5 µM for inhibiting MDR1-mediated Calcein-AM transport and BCRP-mediated Prazosin transport, respectively. CP-100356 hydrochloride is also a weak inhibitor of OATP1B1 (IC50=∼66 µM). CP-100356 hydrochloride is devoid of inhibition against MRP2 and major human P450 enzymes (IC50>15 µM)[1].

Name	4-(6,7-dimethoxy-3,4-dihydro-1H-isoquinolin-2-yl)-N-[2-(3,4-dimethoxyphenyl)ethyl]-6,7-dimethoxyquinazolin-2-amine,hydrochloride
Synonym	More Synonyms

Description	CP-100356 hydrochloride is an orally active dual MDR1 (P-gp)/BCRP inhibitor, with an IC50s of 0.5 and 1.5 µM for inhibiting MDR1-mediated Calcein-AM transport and BCRP-mediated Prazosin transport, respectively. CP-100356 hydrochloride is also a weak inhibitor of OATP1B1 (IC50=∼66 µM). CP-100356 hydrochloride is devoid of inhibition against MRP2 and major human P450 enzymes (IC50>15 µM)[1].
Related Catalog	Signaling Pathways >> Membrane Transporter/Ion Channel >> P-glycoprotein Research Areas >> Metabolic Disease Signaling Pathways >> Membrane Transporter/Ion Channel >> BCRP
Target	IC50: 0.5 µM (MDR1), 1.5 µM (BCRP) in MDCKII cells[1]
In Vitro	CP-100356 (0.1-15 µM; pretreated for 30 min) inhibits acetoxymethyl Calcein (Calcein-AM) uptake and and Digoxin transport in human MDR1-transfected MDCKII cells, with IC50s of 0.50 µM and 1.2 µM, respectively. CP-100356 decreases the BCRP-mediated transport of Prazosin in MDCKII cells, with an IC50 of 1.5 µM[1]. CP-100356 (0.064-200 µM; 5 min) inhibits OATP1B1-mediated uptake of Estradiol 17β-D-Glucuronide, with an IC50 of ~66 µM[1]. CP-100356 (0-50 µM; 10-30 min) is devoid of inhibition (IC50>50 µM) against the catalytic activity of the individual P450 enzymes including P4503A4 in the competitive inhibition study[1].
In Vivo	CP-100356 (6-24 mg/kg; p.o.) increases the systemic exposure of Fexofenadine (36- and 80-fold increase in Cmax and AUC at the dose of 24 mg/kg) in rats[1].
References	[1]. Kalgutkar AS, et, al. N-(3,4-dimethoxyphenethyl)-4-(6,7-dimethoxy-3,4-dihydroisoquinolin-2[1H]-yl)-6,7-dimethoxyquinazolin-2-amine (CP-100,356) as a "chemical knock-out equivalent" to assess the impact of efflux transporters on oral drug absorption in the rat. J Pharm Sci. 2009 Dec;98(12):4914-27.

Molecular Formula	C₃₁H₃₇ClN₄O₆
Molecular Weight	597.10200
Exact Mass	596.24000
PSA	99.66000
LogP	5.18760

CP-100356 hydrochloride MSDS(Chinese)

Hazard Codes	Xi
RIDADR	NONH for all modes of transport

CP-100356 Hydrochloride

DC Chemicals Limited
China
Product Name: CP 100356
Price: $Inquiry/100mg $Inquiry/250mg $Inquiry/500mg
Purity: 98.0%
Stocking Period: 3 Day
Contact: Tony Cao

Dayang Chem (Hangzhou) Co., Ltd.
China
Product Name: 4-(3,4-Dihydro-6,7-dimethoxy-2(1H)-isoquinolinyl)-N-[2-(3,4-dimethoxyphenyl)ethyl]-6,7-dimethoxy-2-quinazolinamine Monohydrochloride
Price: $Inquiry/100g $Inquiry/1kg $Inquiry/100kg $Inquiry/1000kg
Purity: 98.0%
Stocking Period: Inquiry
Contact: Ms Wang

Get all suppliers and price by the below link:

CP-100356 hydrochloride suppliers

Price: ￥4500/5 mg

Reference only. check more CP-100356 hydrochloride price

CP-100356 hydrochloride

Use of CP-100356 hydrochloride

Names

CP-100356 hydrochloride Biological Activity

Chemical & Physical Properties

MSDS

Safety Information

Synonyms